Skip to main content

Advertisement

ADVERTISEMENT

Interviews

Interview
12/28/2016
Johannes Lammer, MD, is professor of radiology and interventional radiology at the Medical University of Vienna in Vienna, Austria. Dr. Lammer is principal investigator for the ESPRIT I trial, which evaluated the safety and performance of the...
Johannes Lammer, MD, is professor of radiology and interventional radiology at the Medical University of Vienna in Vienna, Austria. Dr. Lammer is principal investigator for the ESPRIT I trial, which evaluated the safety and performance of the...
Johannes Lammer, MD, is...
12/28/2016
Vascular Disease Management
Interview
12/04/2016
At VEITH Symposium, Dr. Ansel shared new findings from subanalyses as well as 5-year results that show widening benefits from the drug-eluting stent.
At VEITH Symposium, Dr. Ansel shared new findings from subanalyses as well as 5-year results that show widening benefits from the drug-eluting stent.
At VEITH Symposium, Dr. Ansel...
12/04/2016
Vascular Disease Management
Interview
10/31/2016
The 1-year results from IN.PACT Global confirm safety and effectiveness of the In.Pact Admiral DCB in femoropopliteal lesions. Michael R. Jaff, DO, answers questions about the results and their implications for peripheral vascular therapy.
The 1-year results from IN.PACT Global confirm safety and effectiveness of the In.Pact Admiral DCB in femoropopliteal lesions. Michael R. Jaff, DO, answers questions about the results and their implications for peripheral vascular therapy.
The 1-year results from IN.PACT...
10/31/2016
Vascular Disease Management
Interview
07/05/2016
New technologies are forthcoming in venous disease, and there is a growing interest in venous therapy among operators previously focusing on only arterial disease. Venous disease specialist Seshadri Raju, MD, described the changes that need...
New technologies are forthcoming in venous disease, and there is a growing interest in venous therapy among operators previously focusing on only arterial disease. Venous disease specialist Seshadri Raju, MD, described the changes that need...
New technologies are forthcoming...
07/05/2016
Vascular Disease Management
Interview
07/05/2016
Ghassan S. Kassab, PhD, an engineer who developed a sizing device for interventional procedures, champions collaboration among physicians, scientists, and engineers to create the most effective medical devices.
Ghassan S. Kassab, PhD, an engineer who developed a sizing device for interventional procedures, champions collaboration among physicians, scientists, and engineers to create the most effective medical devices.
Ghassan S. Kassab, PhD, an...
07/05/2016
Vascular Disease Management
Interview
07/05/2016
William Lombardi, MD, describes a treatment algorithm developed by himself and his colleagues to treat coronary chronic total occlusions and discusses how this algorithm could translate to peripheral vascular therapy.
William Lombardi, MD, describes a treatment algorithm developed by himself and his colleagues to treat coronary chronic total occlusions and discusses how this algorithm could translate to peripheral vascular therapy.
William Lombardi, MD, describes...
07/05/2016
Vascular Disease Management
Interview
07/05/2016
William Lombardi, MD, describes a treatment algorithm developed by himself and his colleagues to treat coronary chronic total occlusions and discusses how this algorithm could translate to peripheral vascular therapy.
William Lombardi, MD, describes a treatment algorithm developed by himself and his colleagues to treat coronary chronic total occlusions and discusses how this algorithm could translate to peripheral vascular therapy.
William Lombardi, MD, describes...
07/05/2016
Vascular Disease Management
Interview
05/22/2016
Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study.
Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study.
Dheeraj K. Rajan, MD, FRCPC,...
05/22/2016
Vascular Disease Management
Interview
05/22/2016
Michael Temple, MD, discusses results from a multi-institutional study of inferior vena cava (IVC) filter use in children. The study’s goal was to determine success rates, complications, and outcomes as well as usage patterns for IVC filters...
Michael Temple, MD, discusses results from a multi-institutional study of inferior vena cava (IVC) filter use in children. The study’s goal was to determine success rates, complications, and outcomes as well as usage patterns for IVC filters...
Michael Temple, MD, discusses...
05/22/2016
Vascular Disease Management
Interview
05/22/2016
Michael Temple, MD, discusses results from a multi-institutional study of inferior vena cava (IVC) filter use in children. The study’s goal was to determine success rates, complications, and outcomes as well as usage patterns for IVC filters...
Michael Temple, MD, discusses results from a multi-institutional study of inferior vena cava (IVC) filter use in children. The study’s goal was to determine success rates, complications, and outcomes as well as usage patterns for IVC filters...
Michael Temple, MD, discusses...
05/22/2016
Vascular Disease Management

Advertisement

Advertisement

Advertisement